Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEGASYS Duration and Dose in HBeAg Positive Chronic Hepatitis B
NCT00435825Phase 4Completed
- Sponsor
- Roche
- Start
- Mar 2007
- Primary completion
- Dec 2010
- Modality
- Cytokines & Interferons
- Countries
- 13
01
Overview
A Phase 4 trial of pegylated interferon alpha in Chronic Hepatitis B (CHB), sponsored by Roche. Started Mar 2007; status: completed.
02
Drugs
pegylated interferon alpha
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00435825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00435825.